Latest Biotech Startup Funding Rounds

Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.

This page showsSector: Biotech
Rounds
603
All time
Disclosed funding
$28.7B
480 disclosed amounts
Median round
$17M
Of disclosed amounts
603 rounds
Funding rounds
CompanyAmountRoundSectorCountryInvestorsAnnounced
Barnwell BioBiotech · United StatesCompany profile

Provides metagenomic biosurveillance for poultry producers to detect disease threats early

Provides metagenomic biosurveillance for poultry producers to detect disease threats early

$6MSeedBiotechUnited StatesInvestors
Fortitude BiomedicinesBiotech · United StatesCompany profile

Develops antibody-based therapies for autoimmune diseases and cancer

Develops antibody-based therapies for autoimmune diseases and cancer

$13MSeedBiotechUnited StatesInvestors
Resolve M TherapeuticsBiotech · United StatesCompany profile

Builds pro-resolution platform for target ID and drug discovery for inflammatory diseases

Builds pro-resolution platform for target ID and drug discovery for inflammatory diseases

UndisclosedUndisclosedBiotechUnited StatesInvestors
Octarine BioBiotech · DenmarkCompany profile

Octarine Bio develops bio-based pigments through precision fermentation for textiles and other industrial applications.

Octarine Bio develops bio-based pigments through precision fermentation for textiles and other industrial applications.

€5MSeries A extensionSeries ABiotechDenmarkInvestors
MendraBiotech · United StatesCompany profile

Develops and commercializes rare disease therapies using AI

Develops and commercializes rare disease therapies using AI

$82MSeries ABiotechUnited StatesInvestors
Corxel PharmaceuticalsBiotech · ChinaCompany profile

Corxel Pharmaceuticals develops clinical-stage medicines for cardiometabolic diseases, including obesity, diabetes, stroke and hypertension.

Corxel Pharmaceuticals develops clinical-stage medicines for cardiometabolic diseases, including obesity, diabetes, stroke and hypertension.

≤$287MSeries D1Series C+BiotechChinaInvestors
InfinitopesBiotech · United KingdomCompany profile

Develops precision therapeutic vaccines against multiple solid tumour indications

Develops precision therapeutic vaccines against multiple solid tumour indications

$15.4MSeedBiotechUnited KingdomInvestors
PraxisProBiotech · United StatesCompany profile

Provides AI-powered commercial intelligence for Life Sciences organizations

Provides AI-powered commercial intelligence for Life Sciences organizations

$6MSeedBiotechUnited StatesInvestors
Think BioscienceBiotech · United StatesCompany profile

Develops small molecule drugs for historically challenging drug targets

Develops small molecule drugs for historically challenging drug targets

$55MSeries ABiotechUnited StatesInvestors
ExcivaBiotech · GermanyCompany profile

Develops novel therapies for behavioral symptoms associated with Alzheimer's Disease

Develops novel therapies for behavioral symptoms associated with Alzheimer's Disease

€51MSeries BBiotechGermanyInvestors

Active investors in this selection

All investors →

Ranked by rounds participated in · All time

  1. 1
    RA Capital Management

    Delix Therapeutics, Alethio Therapeutics, Estuary Biotherapeutics

    27rounds
    6led
  2. 2
    Eli Lilly and Company

    Oyster Therapeutics, BigHat Biosciences, Circle Pharma, Inc.

    16rounds
    0led
  3. 3
    Janus Henderson Investors

    Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics

    16rounds
    1led
  4. 4
    ARCH Venture Partners

    Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences

    16rounds
    1led
  5. 5
    OrbiMed

    Dren Bio, Star Therapeutics, Leal Therapeutics

    12rounds
    1led

Latest digests

Archive →

Explore published rounds while the next edition is being prepared.

Browse rounds by topic